C3252265||Salvianolic Acids
C1272883||Injection
C1272883||Salvianolic Acids for Injection
C1155266||inflammatory responses
C0206116||microglia
C0270611||brain damage
C0917798||focal cerebral ischemia
C0021368||Inflammatory reactions
C0206116||microglia
C0006104||brain
C0007786||ischemia
C3854511||reperfusion (I/R) cerebral injuries
C0206116||Microglia
C2247725||TLR4
C1513838||NF-κB signal pathways
C3252265||Salvianolic acids
C1272883||injection
C1272883||Salvianolic Acids for Injection
C0948008||ischemic stroke
C0700287||reported
C2603343||studied
C1272883||Salvianolic Acids for Injection
C1155266||inflammatory responses
C0023810||LPS
C4075604||BV-2
C0206116||microglia
C1272883||Salvianolic Acids for Injection
C1527144||therapeutic effect
C0740391||Middle cerebral artery occlusion
C0740391||Middle cerebral artery occlusion
C0034721||rat
C0012644||model
C0557351||employed
C1272883||Salvianolic Acids for Injection
C0948008||ischemic stroke
C0034721||Rats
C1272883||Salvianolic Acids for Injection
C1272883||Salvianolic Acids for Injection
C0917798||I
C3854511||R injury
C1272883||Salvianolic Acids for Injection
C0021368||neuroinflammation
C0021308||infarction
C0042444||vehicle
C0206116||microglia cells
C2247725||TLR4
C1513838||NF-κB signals
C1272883||Salvianolic Acids for Injection
C0228174||hemisphere
C1171362||expression
C0680255||release
C0079189||cytokines
C0021753||IL-1β
C0021760||IL-6
C2603343||study
C1272883||Salvianolic Acids for Injection
C0006104||brain
C0917798||cerebral ischemia
C0021368||inflammation
C0206116||microglia